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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
16.09.2020 Use of 
antimicrobial 
mouthwashes 
(gargling) and 
nasal sprays 
by healthcare 
workers to 
protect them 
when treating 
patients with 
suspected or 
confirmed 
COVID-19 
infection  
Cochrane 
Systematic 
Review | 
Intervention 
• To assess the benefits 
and harms of 
antimicrobial 
mouthwashes and 
nasal sprays used by 
HCWs to protect 
themselves when 
treating patients with 
suspected or confirmed 
C19 infection 
• No completed studies 
to include in this review 
were found. There are 
3 ongoing studies 
(including 2 RCTs) 
which aim to enrol 
nearly 700 participants. 
Only one of the ongoing 
studies concerning 
specifically states that it 
will evaluate adverse 
events and it is not 
clear if this will include 
changes in the sense of 
small or to the oral and 
nasal microbiota, and 
any consequences 
thereof. 
Antimicrobial 
mouthwashes 
and nasal 
sprays, 
HCWs 
16.09.2020 Use of 
antimicrobial 
mouthwashes 
(gargling) and 
nasal sprays 
administered 
to patients 
with 
suspected or 
confirmed 
COVID-19 
infection to 
improve 
patient 
outcomes 
and to protect 
healthcare 
workers 
treating them 
Cochrane 
Systematic 
Review | 
Intervention 
• To assess the benefits 
and harms of 
antimicrobial 
mouthwashes and 
nasal sprays 
administered to patients 
with suspected or 
confirmed COVID-19 
infection to both the 
patients and the HCWs 
caring for them  
• No completed studies 
to include in this review 
were found. There are 
16 ongoing studies 
(including 14 RCTs) 
which aim to enrol 
nearly 1250 
participants. Concern 
remains that few of the 
ongoing studies 
specifically state that it 
will evaluate adverse 
events and it is not 
clear if this will include 
changes in the sense of 
small or to the oral and 
nasal microbiota, and 
any consequences 
thereof. 
Antimicrobial 
mouthwashes 
and nasal 
sprays, 
patients 
16.09.2020 Antimicrobial 
mouthwashes 
(gargling) and 
nasal sprays 
to protect 
healthcare 
workers when 
undertaking 
aerosol-
generating 
procedures 
(AGPs) on 
patients 
without 
suspected or 
confirmed 
COVID-19 
infection 
Cochrane 
Systematic 
Review | 
Intervention 
• To assess the benefits 
and harms of 
antimicrobial 
mouthwashes and 
nasal sprays 
administered to HCWs 
and/or patients when 
undertaking AGPs on 
patients without 
suspected or confirmed 
COVID-19 infection 
• No completed studies 
to include in this review 
were found and there 
are no ongoing studies 
Antimicrobial 
mouthwashes 
and nasal 
sprays, 
HCWs, 
aerosol-
generating 
procedures 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
18.09.2020 Early 
estimates of 
COVID-19 
infections in 
small, 
medium and 
large 
population 
clusters 
BMJ Global 
Health | 
Article 
• A modelling approach 
to estimate the 
potential impacts of 
C19 in SSA under 
scenarios that cover 
different population 
sizes, urban status, 
effectiveness and 
coverage of social 
distancing, contact 
tracing and usage of 
cloth face mask 
• When implemented 
early, 50% coverage 
of contact tracing and 
face mask, with 33% 
effective social 
distancing policies can 
bring the epidemic to a 
manageable level for 
all population sizes 
and settings assessed 
• Relaxing of social 
distancing in urban 
settings from 33% to 
25% could be 
matched by 
introduction and 
maintenance of face 
make use at 43% 
• In SSA countries with 
limited healthcare 
workforce, hospital 
resources and ICUs, a 
robust system of 
social distancing, 
contact tracing and 
face mask use could 
prevent several 
millions of infections 
and thousands of 
deaths 
Estimates C19 
infection, SSA 
15.09.2020 Report 31 – 
estimating 
under-
ascertainment 
of COVID-19 
ICL | Report 
31 
• One hypothesis that 
countries in the Middle 
East and Africa have 
reported substantially 
lower mortality rates 
than in Europe and the 
Americas is that 
Under-
ascertainment, 
Syria 
mortality: an 
analysis of 
novel data 
sources to 
provide 
insight into 
COVID-19 
dynamics in 
Damascus, 
Syria 
deaths have been 
under-ascertained 
(deaths that have 
been unreported). 
• The scale of under-
ascertainment is 
difficult to assess with 
currently available 
data. Using a 
modelling approach, 
this report estimates 
the potential under-
ascertainment of C19 
mortality in Damascus, 
Syria 
• Exploring a range of 
different assumptions 
about under-
ascertainment, 
authors estimate that 
only 1.25% of deaths 
(sensitivity range 1% 
to 3%) due to C19 are 
reported in Damascus, 
suggesting that 
Damascus is at a 
much later stage in it 
epidemic than 
suggested by 
surveillance reports, 
with an estimated 
4,340 (95% CI 3250-
5540) deaths due to 
C19 that may have 
been missed as of 2 
Sept 2020 
• Given that Damascus 
is likely to have the 
most robust 
surveillance in Syria, 
these findings suggest 
that other regions of 
the country could have 
experienced similar or 
worse mortality rates 
due to C19 
15.09.2020 Seasonality 
of respiratory 
viral 
infections: will 
COVID-19 
follow suit? 
Frontiers in 
Public Health 
| Review 
article 
• This review of current 
knowledge on the 
seasonality of 
respiratory viruses and 
the viral and host 
factors that govern 
their seasonal pattern, 
attempts to address 
the question if SARS-
seasonality 
CoV-2 will eventually 
become seasonal or 
will it continue to 
circulate year-round 
• Also discusses the 
properties of SARS-
CoV-2 and the 
potential impact of 
meteorological factors 
on its spread 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 17.09.2020 Assessing a 
novel lab-free, 
point-of-care 
test for SARS-
CoV-2 
(CovidNudge): 
a diagnostic 
accuracy 
study 
 The Lancet 
Microbe | 
Article 
• A novel, rapid POC 
real time RT-PCR 
CovidNudge test, 
which requires no 
laboratory handling or 
sample pre-
processing 
• Accuracy was 
compared with 
standard laboratory 
RT-PCR in 386 paired 
nasopharyngeal swab 
samples collected 
from self-referred 
HCWs, patients in the 
emergency 
department and 
hospital inpatient 
admissions from 3 
hospitals in UK 
• CovidNudge was a 
sensitive, specific and 
rapid POC test for the 
presence of SARS-
CoV-2 without 
laboratory handling or 
sample pre-
processing 
• Results support a role 
for CovidNudge POC 
test as part of the 
strategies to improve 
access to rapid 
diagnostics to SARS-
CoV-2 
POC test 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
 18.09.2020 Artificial 
intelligence 
in COVID-19 
drug 
repurposing  
 The Lancet 
Digital Health 
| Review 
• In this review, authors 
introduce guidelines on 
how to use AI for 
accelerating drug 
repurposing or 
repositioning. Authors 
argue that AI approaches 
are not just formidable but 
are also necessary 
• Authors discuss how to 
use AI models in 
precision medicine and 
how AI models can 
accelerate C19 drug 
repurposing 
 Drug 
repurposing 
, AI 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
Sept 2020 Emerging 
evidence 
on 
shielding 
groups 
during 
COVID-
19  
SSHAP | Brief 
• Following on from a previous 
brief on general principles of 
shielding, this brief focuses 
on emerging evidence 
relevant to shielding, 
including research regarding 
social acceptability and 
implementation of shielding 
• Evidence is primarily drawn 
from LMICs 
Shielding, 
social 
acceptability,  
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
16.09.2020 Health and 
human 
rights are 
inextricably 
linked in 
BMJ Global 
Health | 
Analysis 
• Governments throughout the 
world have introduced 
emergency measures that 
constrain individuals 
freedoms, social and 
economic rights and global 
 Human 
rights 
the COVID-
19 
response 
solidarity to mitigate the 
spread of C19 
• The norms and principles of 
human rights should guide 
government responses to 
C19 with these rights 
strengthening the public 
health response to C19 
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
Sept 2020 Broader 
health 
impacts of 
vertical 
responses 
to COVID-
19 in low 
and 
middle-
income 
countries 
(LMICs) 
SSHAP | Brief 
• A review of the effects of 
vertical responses to COVID-
19 on health systems, 
services and people’s access 
to and use of them in LMICs, 
where historic and ongoing 
under-investments heighten 
vulnerability to a multiplicity 
of health threats 
Vertical 
responses 
Comments, Editorials, Opinions, Blogs, News  
Publication 
date 
Title/URL Journal | Article type 
21.09.2020 Supporting people who experience violence 
during the COVID-19 pandemic 
ARISE | Blog 
18.09.2020 What questions we should be asking about 
COVID-19 in humanitarian settings: 
perspectives from the social Sciences 
Analysis Cell in the Democratic Republic of 
the Congo 
BMJ Global Health | Commentary 
18.09.2020 Safety and efficacy of the Russian COVID-
19 vaccine: more information needed 
The Lancet | Correspondence 
18.09.2020 Safety and efficacy of the Russian COVID-
19 vaccine: more information needed- 
authors’ reply 
The Lancet | Correspondence 
18.09.2020 Severe COVID-19 infection – knowledge 
gained and remaining questions 
JAMA Internal Medicine | Editorial 
17.09.2020 Who gets a COVID vaccine first? Access 
plans are taking shape 
Nature | News 
16.09.2020 The evolving picture of SARS-CoV-2 and 
COVID-19 in children: critical knowledge 
gaps 
BMJ Global Health | Commentary 
04.09.2020 What do we know about women and 
COVID-19 in low- and middle-income 
countries from the peer-reviewed literature? 
Gender & COVID-19 | Research 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
15.09.2020 An expanded tool 
to estimate the net 
health impact of 
COVID-19 policies 
CGD | 
Tool 
• A new version of a tool to estimate 
the net health impacts of COVID-19 
policies in support of decision-
makers in estimating the impact of 
different strategies to tackle C19 
using a whole-of-health approach 
Sept 2020 2020 Goalkeepers 
Report: COVID-19 
A Global 
Perspective 
BMGF | 
Annual 
report 
• 18 indicators included in the SDGs 
are tracked where progress has 
been seen in recent years, this year 
most have regressed 
• Two goals of the report are to (i) 
analyse the damage the pandemic 
has done and is still doing to health, 
economies etc and (ii) argue for a 
collaborative response 
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Dashboards & Trackers 
Cases & deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living evidence & 
policy maps 
Current research 
including trials 
  Diagnostics   Treatments   Vaccines 
WHO sitreps  WHO Africa  Ghana  COVID-NMA  WHO    FIND SARS-
CoV-2 Test 
Tracker 
  Global COVID-
19 Clinical Trial 
Tracker 
  CEPI 
WHO dashboard  African 
Arguments  
Indonesia  EPPI Centre  WHO International 
Clinical Trials 
Registry Platform 
(ICTRP)  
 FIND SARS-
CoV-2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM  
Johns Hopkins 
University  
European 
CDC  
Nigeria CDC  Norwegian 
Institute of Public 
Health  
Cytel   Serology-based 
tests for COVID-
19 
  Solidarity trial  COVID-19 
Oxford 
Vaccine Trial 
WEF    Sierra Leone   Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH   Our World in 
Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-19 
Vaccine 
Tracker 
Our World in 
Data  
  Singapore   Our World in 
Data: C19 Policy 
responses 
COVID-evidence        
Global 5050    UK   IFPRI COVID-19 
Policy Response 
Portal 
Cochrane        
CEBM, University 
of Oxford  
  US   COVID-19 
Primer 
Clinicaltrials.gov        
Humanitarian 
Data Exchange  
     NIH LitCovid  UKCDR       
Information is 
Beautiful  
     WHO COVID-19 
Database 
        
LSHTM                
HealthMap 
(cases) 
              
The Commons 
Project 
              
SeroTracker                
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y 
C19 Resource Hubs 
Global  Regional 
& Country 
Academi
c 
journals 
& 
Publisher
s 
Institutes/Centres/Funders/
Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa 
CDC 
Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicati
on 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambrid
ge 
Universit
y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy 
of 
Sciences 
Cochran
e  
Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Developm
ent Direct 
C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID Repository     
UNOCHA OCHA 
Southern 
and 
Eastern 
Africa 
COVID-19 
Digest 
Health 
Policy 
and 
Planning  
Norwegian Institute of 
Public Health 
    
UNHCR  South 
African 
Governme
nt 
JAMA 
Network 
Oxford Centre for 
Evidence-based Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprint
s) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
Universit
y Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources and 
Analyses of C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent Epidemics      
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David 
Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprint
s)  
      
Humanitarian 
OpenStreetM
ap Team 
  Wiley       
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global 
Impact Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
02.10.2020 Understanding and 
Improving COVID-19 
Vaccine Portfolio 
Online event 1h30 CGD 
21.09.2020 Mitigating the 
Economic and Health 
Online event 1h30 CGD, GF, AU 
Impact of COVID-19 
across Africa 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
(Geneva 
time) 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid weekly search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary research 
papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease control 
and health system responses are included. Articles related to tackling the secondary impacts on other sectors are 
not included. Additional commentaries, opinions, and commissioned pieces are selected based on relevance. 
  
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Foreign, Commonwealth 
and Development Office (FCDO) and its partners in support of pro-poor programmes. Except 
where otherwise stated, it is licensed for non-commercial purposes under the terms of the 
Open Government Licence v3.0. K4D cannot be held responsible for errors, omissions or 
any consequences arising from the use of information contained in this health evidence 
summary. Any views and opinions expressed do not necessarily reflect those of FCDO, K4D 
or any other contributing organisation.  
© Crown copyright 2020. 
 
